Stay updated on Immunotherapy with TILs in Metastatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page.

Latest updates to the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page’s footer/version label has been updated from one software revision to the next (v3.5.2 to v3.5.3), indicating a site release rather than a change to the trial record.SummaryDifference0.0%

- Check9 days agoChange Detected- Revision: v3.5.2 (updated from v3.5.0)SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check38 days agoChange DetectedVersion metadata updated to add revision v3.5.0 and remove revision v3.4.3.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision: v3.4.3 was added, replacing the previous v3.4.2.SummaryDifference0.0%

- Check52 days agoChange DetectedThe study record was updated on 2026-03-03 and 2026-03-04. These updates add the latest status and details of the trial.SummaryDifference0.2%

- Check60 days agoChange DetectedUpdates on 2026-02-24 and 2026-02-25 added new information to the study record, notably the data sharing plan for individual participant data (IPD) and related study details. Deletions on 2026-02-14 and 2026-02-17 removed older or redundant entries from the page.SummaryDifference0.1%

Stay in the know with updates to Immunotherapy with TILs in Metastatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page.